首页 | 本学科首页   官方微博 | 高级检索  
检索        

白血病化疗药物MTT法体外敏感试验的临床意义(附14例分析)
引用本文:徐健,马兰英,郭宝强,李银杰,李登华,张建华,田志刚,崔正言.白血病化疗药物MTT法体外敏感试验的临床意义(附14例分析)[J].山东大学学报(医学版),1994(3).
作者姓名:徐健  马兰英  郭宝强  李银杰  李登华  张建华  田志刚  崔正言
作者单位:山东省立医院内科,山东省医学科学院基础医学研究所
摘    要:应用MTT法对14例白血病患者进行了DNR、Har、Ara-c、VCR、ADM和VP_(16)等6种常用化疗药物的体外敏感试验及临床观察。按体外药敏结果选择药物组成方案进行化疗,杀伤指数>55%者占66.7%,未按药敏结果组成方案进行化疗,杀伤指数>55%者仅占25%,二者差异有显著性,表明体外药敏与临床用药间有一定关系。

关 键 词:白血病,药物疗法.联合,MTT法,幼稚细胞杀伤指数

CLINICAL SIGNIFICANCE OF CHEMOSENSITIVITY TEST (MTT) IN VITRO OF LEUKEMIA
Xu Jian, Ma Lanying, Guo Baoqiang,et al.CLINICAL SIGNIFICANCE OF CHEMOSENSITIVITY TEST (MTT) IN VITRO OF LEUKEMIA[J].Journal of Shandong University:Health Sciences,1994(3).
Authors:Xu Jian  Ma Lanying  Guo Baoqiang  
Abstract:Six common anti-cancer drugs(DNR,Har,Ara-c,VCR,ADM and VP_(16)) to the leukemic cells from 14 patients with leukemia were tested in vitro with MTT (chemosensitivity test). In this group with chemothera peutic protocol based upon the selected drugs from this chemosensitivity test, the marrow blasts decrease index is 55% or more than 55% were 66.7%. But in group with the protocol not based upon the results of the chemosensitivity, the patients with marrow blasts decrease index is 55% or more than 55% were only 25%. The difference of the positive percentage between these two groups were significant. The results indicated that there were certain association between MTT assay chemosensitivity and the response of patients leukemic cells to chemotherapy.
Keywords:Leukemia  Drug therapy  combination  MTT assay  MBDI
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号